| Overview |
| bsm-90210r-50µL |
| Phospho-PBK/TOPK (Thr9) Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Phospho-PBK/TOPK (Thr9) |
| 2-16/322 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 55872 |
| Q96KB5 |
| PBK; PDZ Binding Kinase; TOPK; CT84; SPK; T-LAK Cell-Originated Protein Kinase; Cancer/Testis Antigen 84; Nori-3; Lymphokine-Activated Killer T-Cell-Originated Protein Kinase; Spermatogenesis-Related Protein Kinase; MAPKK-Like Protein Kinase; FLJ14385; Serine/Threonine Protein Kinase; Epididymis Luminal Protein 164; PDZ-Binding Kinase; EC 2.7.12.2; HEL164; NORI-3 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |